Author

J. Lafleur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Aguilar-Mahecha· 1 shared C. H. Borchers· 1 shared G. Batist· 1 shared G. Mitsa· 1 shared L. Florianova· 1 shared M. Basik· 1 shared R. P. Zahedi· 1 shared S. V. Del Rincon· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Aguilar-Mahecha

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategies.

G. Mitsa, L. Florianova, J. Lafleur, A. Aguilar-Mahecha, R. P. Zahedi, S. V. Del Rincon, M. Basik, C. H. Borchers, G. Batist

The paper uses clinical proteomics to identify biomarkers and metabolic vulnerabilities in DCIS, informing therapeutic strategies and developing a targeted proteomics assay for cancer-related pathways.

bioRxiv · Jul 11, 2023 · PreprintCancer Biology